First international proficiency study on human papillomavirus testing in cervical cancer screeningEmel Yilmaz, Joakim Dillner, Carina Eklund et al.|Journal of Clinical Virology|2023Cited by 19
Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated womenMònica Ortega Llobet, Matti Lehtinen, Iacopo Baussano et al.|International Journal of Cancer|2025Cited by 5
Assessment of Human Papillomavirus Non-16/18, Type-Specific Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse Among Women With Cervical Atypical Glandular CellsEmel Yılmaz, Miriam Elfström, Camilla Lagheden et al.|Obstetrics and Gynecology|2023Cited by 4
Antibodies to SARS-CoV-2 and risk of future sicknessJoakim Dillner, Kalle Conneryd Lundgren, Miriam Elfström et al.|medRxiv|2020Cited by 3